Investors Eye Catching Stocks: (NASDAQ:ANAC), (NYSE:RDN)
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindness, and lymphatic filariasis, commonly known as elephantiasis) and tuberculosis (TB).
View full press release